Seek your lover in the daytime, says Ovid. Be careful of the night. You won't choose the right person if you're drunk. And ...

Non-dilutive funding extends Ovid’s operational runway; Immedica assumes certain ganaxolone IP costsNEW YORK and STOCKHOLM, ...

This week saw private and state-owned developers sign contracts valued at 67 billion Birr for the construction of more than 4 ...

A hidden gem in the hamlet of Willard is once again welcoming visitors for the summer harvest. Juneberry Farm, located at ...

An Ovid man is facing a DWI charge after allegedly failing to yield at a stop sign and nearly causing a crash, according to ...

First-degree relatives of women with PCOS showed significantly higher rates of metabolic disorders, revealing a familial ...

Ovid is developing: OV329, a next-generation GABA-aminotransferase inhibitor, as a potential therapy for treatment-resistant seizures and other undisclosed indications; OV350, OV4071 and others ...

The Frick’s first post-renovation show unites three Vermeer masterpieces that explore letter-writing and (maybe) love affairs ...

Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to developing small molecule medicines for brain conditions ...

Ovid is also planning to initiate a Phase 2a patient study for OV329 in early 2026. Additionally, results from a first-in-human safety and exploratory biomarker study with OV350 are expected in ...

The amount of talent amongst Argus-Press-area boys and track field in 2025 was off the charts.Chesaning won another state ...